腹腔镜胆囊切除术中吲哚菁绿微剂量荧光胆道造影的最低有效剂量探索
该回顾性研究比较了腹腔镜胆囊切除术中术中静脉给予0.5 mg吲哚菁绿(ICG)微剂量方案与术前60-120分钟给予7.5 mg标准剂量方案对胆道可视化的效果。结果显示两组在胆囊管、胆总管和肝总管可视化频率及信号强度、清晰度、临床决策有用性评分上均无显著差异,表明术中ICG微剂量方案可提供非劣效的胆道可视化,并简化围术期流程。
要点
- 术中给予0.5 mg ICG微剂量方案与术前7.5 mg标准剂量方案在胆道可视化上效果相当。
- 微剂量组胆囊管可视化率为86.0%,标准剂量组为88.0%,差异无统计学意义(p=0.99)。
- 微剂量方案可在麻醉诱导后给药,省去了术前给药的流程。
核心结论
- 腹腔镜胆囊切除术中术中给予0.5 mg ICG微剂量可提供与术前7.5 mg标准剂量相当的胆道可视化效果。
- 微剂量方案消除了术前ICG给药的 workflow,可能简化围术期管理。
研究设计与样本
- 回顾性队列研究,基于前瞻性维护的数据库,纳入2021至2024年在本机构接受腹腔镜胆囊切除术的患者。
- 共100例患者,微剂量组50例(麻醉诱导后静脉给予0.5 mg ICG),标准剂量组50例(术前60-120分钟静脉给予7.5 mg ICG)。
- 通过手术视频回顾比较胆囊管、胆总管和肝总管的荧光可视化频率,并使用4点Likert量表评估信号强度、背景干扰清晰度和临床决策有用性。
主要发现
- 微剂量组ICG给药至切皮的平均时间为16.7 ± 5.6分钟,平均手术时间为47.4 ± 20.2分钟。
- 肝胆囊三角解剖前胆囊管可视化率:微剂量组86.0% vs 标准剂量组88.0%(p=0.99)。
- 两组胆总管和肝总管在所有病例中均可见。
- 信号强度平均评分:微剂量组3.6 ± 0.5 vs 标准剂量组3.7 ± 0.5(p=0.32)。
- 信号清晰度平均评分:微剂量组3.4 ± 0.5 vs 标准剂量组3.3 ± 0.5(p=0.32);临床决策有用性平均评分:两组均为4.0 ± 0.0(p=0.99)。
临床怎么用
- 对于接受腹腔镜胆囊切除术的患者,可考虑在麻醉诱导后静脉给予0.5 mg ICG进行术中荧光胆道造影,以替代术前给药方案。
- 该微剂量方案可能减少术前用药步骤,优化手术室工作流程。
局限性
- 本研究为单中心回顾性研究,样本量有限(共100例),结论需前瞻性多中心研究验证。
- 未报告患者纳入排除标准、基线特征及潜在混杂因素的控制情况。
- 未评估不同ICG剂量或给药时机对胆道损伤等临床结局的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Fluorescence cholangiography (FC) with indocyanine green (ICG) enables real-time intraoperative visualization of extrahepatic biliary anatomy during laparoscopic cholecystectomy (LC). There is no consensus on the optimal ICG dose or timing of administration for LC. The goal of this study was to implement a simple intraoperative low-dose ("microdose") ICG protocol that facilitates non-inferior biliary visualization compared to a standard dose protocol to streamline perioperative workflows. METHODS: A retrospective review of a prospectively maintained database identified patients who underwent LC at our institution from 2021 to 2024. Microdose protocol patients were intravenously administered 0.5 mg ICG upon induction of general anesthesia, while standard protocol patients received 7.5 mg ICG 60-120 min preoperatively. Operative video from cases in both groups were reviewed to compare the frequency of cystic duct (CD), common bile duct (CBD), and common hepatic duct (CHD) visualization with FC. A 4-point Likert scale survey was completed for each case to compare ICG signal strength (1 = no signal; 4 = very strong), clarity from background interference (1 = cannot discern signal from background; 4 = no interference), and usefulness in clinical decision-making (1 = no benefit; 4 = essential). RESULTS: A total of 100 patients were identified (N = 50 microdose; N = 50 standard). For microdose cases, the mean time from ICG administration to skin incision was 16.7 ± 5.6 min, and mean operative time was 47.4 ± 20.2 min. Compared to 50 standard dose cases, CD visualization before hepatocystic triangle dissection with the microdose protocol was 86.0% vs 88.0% (p = 0.99). The CBD and CHD were seen in all cases for both groups. There were no significant differences in average score for signal strength (3.6 ± 0.5 vs 3.7 ± 0.5, p = 0.32), signal clarity (3.4 ± 0.5 vs 3.3 ± 0.5, p = 0.32), or usefulness in clinical decision-making (4.0 ± 0.0 vs 4.0 ± 0.0, p = 0.99) between groups. CONCLUSION: Microdose ICG can be given intraoperatively to provide excellent biliary visualization during laparoscopic cholecystectomy, eliminating the historical workflow of preoperative ICG administration.
引用
- Broderick RC, Spurzem GJ, Cabrera AG, et al. How low can you go? Intraoperative microdosing of indocyanine green for fluorescence cholangiography during laparoscopic cholecystectomy. Surg Endosc. 2025. PMID: 40789781. doi:10.1007/s00464-025-12057-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。